Alex Michotte
- Genetics top 1%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 5%
- Pulmonary and Respiratory Medicine top 5%
- Oncology top 10%
- Co-authors
- C. ChaskisBart NeynsJan SadonesTadeusz StadnikJohnny DuerinckHendrik EveraertMichel OsteauxJacques De Grève
- Topics
- Glioma Diagnosis and Treatment (35 papers)Brain Metastases and Treatment (18 papers)Cancer, Hypoxia, and Metabolism (8 papers)
- Partner nations
- BelgiumNetherlandsFinland
In The Last Decade
Alex Michotte
84 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 104
- Genetics 961
- Molecular Biology 529
- Radiology, Nuclear Medicine and Imaging 465
- Pulmonary and Respiratory Medicine 419
- Oncology 339
Countries citing papers authored by Alex Michotte
This map shows the geographic impact of Alex Michotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Michotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Michotte more than expected).
Fields of papers citing papers by Alex Michotte
This network shows the impact of papers produced by Alex Michotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Michotte. The network helps show where Alex Michotte may publish in the future.
Co-authorship network of co-authors of Alex Michotte
This figure shows the co-authorship network connecting the top 25 collaborators of Alex Michotte. A scholar is included among the top collaborators of Alex Michotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Michotte. Alex Michotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 19 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | 33 | |
| 7 | 43 | |
| 8 | 3 | |
| 9 | 56 | |
| 10 | 0 | |
| 11 | 99 | |
| 12 | 8 | |
| 13 | 45 | |
| 14 | 12 | |
| 15 | 58 | |
| 16 | Recent developments in the neuropathological diagnosis of Parkinson's disease and parkinsonism | 2 |
| 17 | 13 | |
| 18 | Facial Nerve Palsy as the Presenting Manifestation of a cerebellopontine Angle Meningeal Melanocytoma. | 1 |
| 19 | 46 | |
| 20 | 10 |
About Alex Michotte
Alex Michotte is a scholar working on Genetics, Neurology and Pulmonary and Respiratory Medicine, having authored 86 papers that have together received 2.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (35 papers), Brain Metastases and Treatment (18 papers) and Cancer, Hypoxia, and Metabolism (8 papers). The work is most often cited by research in Genetics (961 citations), Radiology, Nuclear Medicine and Imaging (465 citations) and Neurology (303 citations). Alex Michotte has collaborated with scholars based in Belgium, Netherlands and Finland. Frequent co-authors include C. Chaskis, Bart Neyns, Jan Sadones, Tadeusz Stadnik, Johnny Duerinck, Hendrik Everaert, Michel Osteaux, Jacques De Grève, Robert Luypaert and K. Van Rompaey. Their work appears in journals such as Journal of Clinical Oncology, Neurology and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.